Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of ETN 50mg twice weekly for 12 weeks followed by reduction to a
maintenance dose of 25mg twice weekly at week 24 with that of combination of ETN 25 mg Twice
Weekly plus Acitretin 10mg BID at week 24 in subjects with moderate to severe psoriasis.